Sustainable Insight Capital Management LLC Increases Holdings in Humana Inc. (NYSE:HUM)

Sustainable Insight Capital Management LLC increased its stake in Humana Inc. (NYSE:HUM - Free Report) by 15.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 39,830 shares of the insurance provider's stock after purchasing an additional 5,300 shares during the period. Humana makes up approximately 5.7% of Sustainable Insight Capital Management LLC's portfolio, making the stock its 6th biggest holding. Sustainable Insight Capital Management LLC's holdings in Humana were worth $12,616,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. CarsonAllaria Wealth Management Ltd. boosted its stake in Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider's stock worth $28,000 after buying an additional 39 shares in the last quarter. Creative Financial Designs Inc. ADV grew its stake in shares of Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider's stock worth $27,000 after purchasing an additional 61 shares during the last quarter. Atwood & Palmer Inc. purchased a new position in shares of Humana during the third quarter valued at approximately $29,000. Hantz Financial Services Inc. bought a new stake in Humana in the second quarter valued at $35,000. Finally, Family Firm Inc. purchased a new position in Humana during the 2nd quarter valued at $37,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Performance

HUM traded up $0.36 during midday trading on Friday, hitting $288.12. 1,691,681 shares of the company traded hands, compared to its average volume of 2,587,340. The company's 50-day moving average is $289.38 and its 200 day moving average is $332.70. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $527.18. The firm has a market capitalization of $34.69 billion, a PE ratio of 25.52, a price-to-earnings-growth ratio of 2.28 and a beta of 0.52. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping analysts' consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. On average, research analysts expect that Humana Inc. will post 15.83 EPS for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.23%. The ex-dividend date is Tuesday, December 31st. Humana's dividend payout ratio (DPR) is presently 31.36%.

Wall Street Analyst Weigh In

Several research firms have recently commented on HUM. Barclays raised their target price on shares of Humana from $250.00 to $253.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 31st. UBS Group lowered their price objective on shares of Humana from $380.00 to $250.00 and set a "neutral" rating for the company in a report on Friday, October 4th. KeyCorp initiated coverage on Humana in a research report on Friday, October 11th. They issued a "sector weight" rating for the company. Wells Fargo & Company lowered their target price on Humana from $387.00 to $290.00 and set an "overweight" rating for the company in a research note on Monday, November 4th. Finally, Bank of America raised Humana from an "underperform" rating to a "neutral" rating and upped their price target for the stock from $247.00 to $308.00 in a research note on Wednesday. Twenty investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, Humana has an average rating of "Hold" and a consensus target price of $315.86.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.